Study of bioavailability of oral iron preparations. 1976

K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008297 Male Males
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005296 Ferrous Compounds Inorganic or organic compounds that contain divalent iron. Compounds, Ferrous
D005650 Fumarates Compounds based on fumaric acid. Fumarate,Fumaric Acid Ester,Fumaric Acid Esters,Fumarate Esters,Acid Ester, Fumaric,Acid Esters, Fumaric,Ester, Fumaric Acid,Esters, Fumarate,Esters, Fumaric Acid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
November 1979, Deutsche medizinische Wochenschrift (1946),
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
August 1979, Deutsche medizinische Wochenschrift (1946),
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
August 1979, Deutsche medizinische Wochenschrift (1946),
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
December 1980, Fortschritte der Medizin,
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
January 1977, Journal of pharmaceutical sciences,
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
September 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
August 1979, MMW, Munchener medizinische Wochenschrift,
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
January 1987, Arzneimittel-Forschung,
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
October 1983, Antibiotiki,
K C Gupta, and T Paul, and J M Mehta, and N K Desai, and B Sanghvi, and U K Sheth
October 1978, Lijecnicki vjesnik,
Copied contents to your clipboard!